Robert F. Gagel, M.D.
Robert F. Gagel, M.D., Endocrinologist, is Director, Division of Internal Medicine, and Professor, Department of Endocrine Neoplasia and Hormonal Disorders at the University of Texas MD Anderson Cancer Center in Houston, as well as Adjunct Professor at Baylor College of Medicine. A graduate of Ohio State University Medical School, he completed postgraduate training at Tufts-New England Medical Center, Harvard Medical School, and Harvard School of Public Health. He is a frequent faculty member at medical meetings, serves on numerous committees and advisory groups for professional organizations, and has authored hundreds of peer-reviewed journal articles and other publications. His studies have focused on transcriptional regulation of the calcitonin gene. He and his colleagues identified the new variant of MEN2. Dr. Gagel has also been active in studies of the development of strategies for treatment of medullary thyroid carcinoma.